DOCSLIB.ORG

ICD-10-CM Expert for Physicians the Complete Official Code Set Codes Valid October 1, 2016 Through September 30, 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ICD-10-CM Expert for Physicians the Complete Official Code Set Codes Valid October 1, 2016 Through September 30, 2017 ICD-10-CM Expert for Physicians The complete official code set Codes valid October 1, 2016 through September 30, 2017 ICD-10 IS NOW. For more resources and training visit Optum360Coding.com. Contents Preface ................................................................................ iii ICD-10-CM Neoplasm Table ............................................ 328 ICD-10-CM Official Preface ........................................................................iii Characteristics of ICD-10-CM ....................................................................iii ICD-10-CM Table of Drugs and Chemicals ...................... 346 What’s New for 2017 ........................................................... iv ICD-10-CM Index to External Causes ............................... 394 Introduction ........................................................................ v ICD-10-CM Tabular List of Diseases and Injuries ............ 429 History of ICD-10-CM ..................................................................................v Chapter 1. Certain Infectious and Parasitic Diseases ICD-10-CM: The Complete Official Code Set .................................. v (A00-B99) .........................................................................429 Chapter 2. Neoplasms (C00-D49) ...................................................451 How to Use ICD-10-CM for Physicians 2017........................ vi Chapter 3. Diseases of the Blood and Blood-forming Organs Use of Official Sources ................................................................................vi and Certain Disorders Involving the Immune Steps to Correct Coding ............................................................................vi Mechanism (D50-D89) ..................................................487 Organization .................................................................................................vi Chapter 4. Endocrine, Nutritional and Metabolic Diseases Introduction ..........................................................................................vi (E00-E89) ..........................................................................497 Official ICD-10-CM Conventions and Guidelines..........................vi Chapter 5. Mental, Behavioral, and Neurodevelopmental Alphabetic Index to Diseases ............................................................vi Disorders (F01-F99) .......................................................517 Neoplasm Table....................................................................................vi Chapter 6. Diseases of the Nervous System (G00-G99) ............539 Table of Drugs and Chemicals ..........................................................vi Index to External Causes ....................................................................vi Chapter 7. Diseases of the Eye and Adnexa (H00-H59) ............558 Tabular List of Diseases ......................................................................vi Chapter 8. Diseases of the Ear and Mastoid Process Appendixes............................................................................................vi (H60-H95) ........................................................................592 Illustrations...........................................................................................vii Chapter 9. Diseases of the Circulatory System (I00-I99) ...........604 Chapter 10. Diseases of the Respiratory System (J00-J99) .........642 Overview of ICD-10-CM Official Conventions .................. viii Chapter 11. Diseases of the Digestive System (K00-K95) ...........656 Format ................................................................................................viii Punctuation ................................................................................................viii Chapter 12. Diseases of the Skin and Subcutaneous Tissue (L00-L99) ..........................................................................678 Abbreviations .............................................................................................viii NEC ........................................................................................................viii Chapter 13. Diseases of the Musculoskeletal System and Connective Tissue (M00-M99) ....................................697 NOS........................................................................................................viii Typeface...... ................................................................................................viii Chapter 14. Diseases of the Genitourinary System (N00-N99) .781 General Notes ............................................................................................viii Chapter 15. Pregnancy, Childbirth and the Puerperium Includes Notes ....................................................................................viii (O00-O9A) ........................................................................798 Inclusion Terms...................................................................................viii Chapter 16. Certain Conditions Originating in the Perinatal Excludes Notes....................................................................................viii Period (P00-P96) ............................................................835 Note.........................................................................................................ix Chapter 17. Congenital Malformations, Deformations and Default Codes........................................................................................ix Chromosomal Abnormalities (Q00-Q99) .................846 Syndromes.............................................................................................ix Chapter 18. Symptoms, Signs and Abnormal Clinical and And .......................................................................................................... ix Laboratory Findings, Not Elsewhere With .........................................................................................................ix Classified (R00-R99) .......................................................863 Instruction Notes Used in the Tabular ............................................ix Chapter 19. Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) .......................................882 Additional Annotations ....................................................... x Chapter 20. External Causes of Morbidity (V00-Y99)................. 1079 Code-Level Notationsx Chapter 21. Factors Influencing Health Status and Contact Italics ....................................................................................................... x With Health Services (Z00-Z99) ............................... 1140 Color Coding/Symbols ........................................................................ x Chapter-Level Notations ...........................................................................xii Chapter-Specific Guidelines with Coding Examples..................xii Appendixes .....................................................Appendixes–1 Muscle/Tendon Table ........................................................................xii Appendix A: 10 Steps to Correct Coding ......................Appendixes–1 Index Notations ..........................................................................................xii Appendix B: Valid 3-character ICD-10-CM Codes.......Appendixes–3 Following References .........................................................................xii Appendix C: Pharmacology List 2017............................Appendixes–5 Appendix D: Z Codes for Long-Term Drug Use with Associated Drugs ..................................... Appendixes–13 ICD-10-CM Official Guidelines for Coding Appendix E: Z Codes Only as a Principal/First-Listed and Reporting 2016 .............................Coding Guidelines–1 Diagnosis .................................................. Appendixes–15 ICD-10-CM Index to Diseases and Injuries .......................... 1 ICD-10-CM 2017 i Contents Illustrations ....................................................Illustrations–1 Chapter 10. Diseases of the Respiratory Chapter 3. Diseases of the Blood and Blood-forming Organs and System (J00–J99) .......................................Illustrations–27 Certain Disorders Involving the Immune Mechanism Respiratory System ..............................Illustrations–27 (D50–D89) .................................................... Illustrations–1 Upper Respiratory System .................Illustrations–28 Red Blood Cells ...................................... Illustrations–1 Lower Respiratory System .................Illustrations–28 White Blood Cell .................................... Illustrations–1 Paranasal Sinuses ................................Illustrations–28 Platelet ..................................................... Illustrations–2 Lung Segments ....................................Illustrations–29 Coagulation ............................................ Illustrations–2 Alveoli .....................................................Illustrations–29 Spleen Anatomical Location and External Chapter 11. Diseases of the Digestive System Structures ................................................ Illustrations–3 (K00–K95) ....................................................Illustrations–30 Spleen Interior Structures ................... Illustrations–3 Digestive System .................................Illustrations–30 Chapter 4. Endocrine, Nutritional and Metabolic Omentum
Load more

Recommended publications
  • Fy 2020 Acs Ipps
    June 24, 2019 Seema Verma, Administrator Centers for Medicare & Medicaid Services Attention: CMS-1716-P P.O. Box 8013 Baltimore, MD 21244-1850 RE: Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2020 Rates; Proposed Quality Reporting Requirements for Specific Providers; Medicare and Medicaid Promoting Interoperability Programs Proposed Requirements for Eligible Hospitals and Critical Access Hospitals Dear Ms. Verma: On behalf of the over 80,000 members of the American College of Surgeons (ACS), we appreciate the opportunity to submit comments to the Centers for Medicare & Medicaid Services’ (CMS) proposed rule, Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2020 Rates; Proposed Quality Reporting Requirements for Specific Providers; Medicare and Medicaid Promoting Interoperability Programs Proposed Requirements for Eligible Hospitals and Critical Access Hospitals, published in the Federal Register on May 3, 2019. The ACS is a scientific and educational association of surgeons founded in 1913 to improve the quality of care for patients by setting high standards for surgical education and practice. Since a large portion of surgical care is provided in the inpatient hospital setting, the College has a vested interest in CMS’ Inpatient Prospective Payment System (IPPS) and related hospital quality improvement efforts, and we believe that we can offer insight to CMS’ proposed modifications to these policies for fiscal year (FY) 2020. Our comments below are presented in the order in which they appear in the proposed rule.
    [Show full text]
  • Case Report a Fragment of Foley Catheter Balloon As a Cause of Bladder Stone in Woman
    Open Access Case report A fragment of Foley catheter balloon as a cause of Bladder stone in woman El Majdoub Aziz1,&, Mouad Amrani1, Khallouk Abdelhak1, Farih Moulay Hassan1 1Department of Urology, Hassan II Hospital University Center, Fez, Morocco &Corresponding author: El Majdoub Aziz, Department of Urology, Hassan II Hospital University Center, Fez, Morocco Key words: intravésical, foreign body, catheter balloon, recurrent urinary tract infections Received: 08/04/2015 - Accepted: 22/04/2015 - Published: 13/08/2015 Abstract Urinary bladder calculi are rarely seen in women and any history of previous pelvic surgery must, therefore, raise suspicion of an iatrogenic etiology. According to the literature, fewer than 2% of all bladder calculi occur in female subjects and, thus, their presence should provoke careful assessment of the etiology. We report one case of a fragment of Foley catheter balloon as a cause of Bladder stone in 28 years old woman. Weanalyzed the diagnosis, aspect and therapeutic management of this case which is the first described in literature to our knowledge. Pan African Medical Journal. 2015; 21:284 doi:10.11604/pamj.2015.21.284.6770 This article is available online at: http://www.panafrican-med-journal.com/content/article/21/284/full/ © El Majdoub Aziz et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Pan African Medical Journal – ISSN: 1937- 8688 (www.panafrican-med-journal.com) Published in partnership with the African Field Epidemiology Network (AFENET).
    [Show full text]
  • Clinical Presentation, Management and Outcome in Diverticular Colovesical Fistulas - Our Experience
    Jemds.com Original Research Article Clinical Presentation, Management and Outcome in Diverticular Colovesical Fistulas - Our Experience Gaurav Kalra1, Rajeev Thekke Puthalath2, Suraj Hegde3, Narendra Pai4, Amit Kumar5 1Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. 2Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. 3Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. 4Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. 5Department of Urology, K.S. Hegde Medical Academy, NITTE (Deemed to Be University), Mangalore, Karnataka, India. ABSTRACT BACKGROUND Colovesical fistula (CVF) is an abnormal communication between the urinary bladder Corresponding Author: and the large intestine, usually sigmoid colon. Diverticulitis is the most common Dr. Rajeev Thekke Puthalath, cause of CVF in most of the western studies, accounting for approximately 70% of Professor and HOD, cases. Diverticular CVF is uncommon in Asia. This case series shares the experience Department of Urology, K.S. Hegde Medical Academy, of six cases of diverticular CVF in Indian population. NITTE (Deemed to be University) Post Nithyananda Nagar, Deralakatte, METHODS Mangalore-575018, Karnataka, India. Medical records of six patients with diverticular colovesical fistulas during the period E-mail: [email protected] January 2016 - August 2019 were reviewed with regard to symptoms, diagnostic investigations, and management. Various aspects of the disease were analysed to DOI: 10.14260/jemds/2020/466 determine the common features of colovesical fistula in our population. How to Cite This Article: Kalra G, Puthalath RT, Hegde S, et al.
    [Show full text]
  • Review Article Enterovesical Fistulae: Aetiology, Imaging, and Management
    Hindawi Publishing Corporation Gastroenterology Research and Practice Volume 2013, Article ID 617967, 8 pages http://dx.doi.org/10.1155/2013/617967 Review Article Enterovesical Fistulae: Aetiology, Imaging, and Management Tomasz Golabek,1 Anna Szymanska,2 Tomasz Szopinski,1 Jakub Bukowczan,3 Mariusz Furmanek,4 Jan Powroznik,5 and Piotr Chlosta1 1 Department of Urology, Collegium Medicum of the Jagiellonian University, Ulica Grzegorzecka 18, 31-531 Cracow, Poland 2 Department of Interventional Radiology and Neuroradiology, Medical University of Lublin, Ulica Jaczewskiego 8, 20-954 Lublin, Poland 3 Department of Endocrinology and Diabetes, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK 4 Department of Radiology, Central Clinical Hospital Ministry of Interior in Warsaw, ul. Wolowska 137, 02-507 Warsaw, Poland 5 The 1st Department of Urology, Postgraduate Medical Education Centre, European Health Centre in Otwock, ul.Borowa14/18,05-400Otwock,Poland Correspondence should be addressed to Tomasz Golabek; [email protected] Received 3 September 2013; Accepted 29 October 2013 Academic Editor: Iwona Sudoł-Szopinska Copyright © 2013 Tomasz Golabek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background and Study Objectives. Enterovesical fistula (EVF) is a devastating complication of a variety of inflammatory and neoplastic diseases. Radiological imaging plays a vital role in the diagnosis of EVF and is indispensable to gastroenterologists and surgeons for choosing the correct therapeutic option. This paper provides an overview of the diagnosis of enterovesical fistulae. The treatment of fistulae is also briefly discussed.
    [Show full text]
  • Diseases of the Genitourinary System (N00-N99), Age Group and Sex, Canada, 2000 (Number)
    Deaths, by cause - Chapter XIV: Diseases of the genitourinary system (N00-N99), age group and sex, Canada, 2000 (Number) 1. Data source: Statistics Canada, Canadian Vital Statistics, Death Database 2. World Health Organization, International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) 3. The cause of death tabulated is the underlying cause of death. This is defined as (a) the disease or injury which initiated the train of events leading directly to death, or (b) the circumstances of the accident or violence which produced the fatal injury. This underlying cause is selected from a number of conditions listed on the death registration form. 4. Counts in this table exclude deaths of non-residents of Canada. 5. To reduce the size of the table, only causes of death with a frequency of one or more in Canada are reported. Over years, more causes of death will be added as needed. 6. Missing data on sex of the deceased were imputed based on death registration number. 7. The following symbols are used in Statistics Canada publications: (..) for figures not available and (...) for figures not appropriate or not applicable. 8. CANSIM table number 01020534. Deaths, by cause - Chapter XIV: Diseases of the genitourinary system (N00-N99), age group and sex, Canada, 2000 (Number) Deaths, by cause - Chapter XIV Age (years) Total, all ages < 1 1-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 2000 A00-Y98 Total, all causes of death 218,062 1,737 300 254 329 1,049 1,318 1,220 1,645 2,681 3,888 Males 111,742
    [Show full text]
  • WO 2016/065001 Al 28 April 2016 (28.04.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/065001 Al 28 April 2016 (28.04.2016) P O P C T (51) International Patent Classification: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, A61K 35/76 (2015.01) C12N 15/63 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, C12N 15/09 (2006.01) C12N 15/86 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, Number: (21) International Application MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PCT/US2015/056659 PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (22) International Filing Date: SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 2 1 October 2015 (21 .10.201 5) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (30) Priority Data: TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, 62/066,856 2 1 October 2014 (21. 10.2014) U S DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (71) Applicant: UNIVERSITY OF MASSACHUSETTS LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, [US/US]; 225 Franklin Street, Boston, M A 021 10 (US).
    [Show full text]
  • Urology ICD 10
    Urology ICD 10 PATIENT NAME: DOB: APPOINTMENT DATE: √ CODE NEW PATIENT VISIT √ CODE ESTABLISHED PATIENT VISIT √ CODE CONSULTATIONS 99201 Problem Focused 99211 Nurse/MD Visit 99241 Problem Focused 99202 Expanded Problem Focused 99212 Problem Focused 99242 Expanded Problem Focused 99203 Detailed 99213 Expanded Problem Focused 99243 Detailed 99204 Comprehensive 99214 Detailed 99244 Comprehensive 99205 Comprehensive 99215 Comprehensive 99245 Comprehensive SYMPTOMS BLADDER VAGINA R10.84 Abd pain, generalized N30.00 Cystitis acute w/o hematuria N81.10 Cystocele, unspecified R10.11 Right upper quadrant pain N30.01 Cystitis acute w hematuria N81.11 Cystocele, midline R10.12 Left upper quadrant pain N30.20 Chronic w/o hematuria N81.12 Cystocele, lateral R10.2 Pelvic and perineal pain N30.21 Chronic w hematuria N81.3 Complete uterovag. prolapse R10.31 Right lower quadrant pain N30.10 Interstitial w/o hematuria N81.5 Enterocle R10.32 Left lower quadrant pain N30.11 Interstitial w hematuria N81.6 Rectocele R50.9 Fever N21.0 Calculus in bladder N76.0 Vaginitis, acute R30.0 Dysuria N32.0 Bladder neck obstruction N95.2 Atrophic/Senile vaginitis R35.0 Frequency of micturition N32.1 Vesicointestinal fistula R35.1 Nocturia N32.2 Vesicovaginal fistula CONTRACEPTION N39.44 Nocturnal enuresis N31.0 Uninhibited neuropathic Z30.2 Encounter sterilization R39.15 Urgency of urination N31.1 Reflex neuropathic Z30.9 Encounter contraceptive mngmnt N39.41 Urge incontinence N31.2 Flaccid neuropathic N39.3 Stress incontinence (female) (male) N30.40 Irradiation cystitis w/o hematuria SCROTUM/TESTES N39.46 Mixed incontinence N30.41 Irradiation cystitis w hematuria C62.11 CA descended R N32.81 Overactive bladder C62.12 CA descended L R33.0 Retention of urine, drug induced PROSTATE D29.21 Benign neoplasm, testis R R33.8 Other retention of urine R97.2 Elevated PSA D29.22 Benign neoplasm, testis L N13.8 Obstructive/Reflux uropahty N40.0 BPH without LUTS D29.4 Benign neoplasm scrotum R39.12 Weak stream N40.1 BPH with LUTS N46.01 Azoospermia organic N40.2 Nodular prostate w/o LUTS N46.029 Azo.
    [Show full text]
  • ICD-10 Codes Covered Under Medical Nutritional Therapy Services
    ICD-10 Codes covered under Medical Nutrition Therapy services – Effective February 1, 2021* ICD-10 Diagnosis Code Description ICD-10 Diagnosis Code Description A56.01 Chlamydial cystitis and urethritis E24.0 Pituitary-dependent Cushing's disease Congenital adrenogenital disorders associated B20. HIV E25.0 with enzyme deficiency B52.0 Plasmodium malariae malaria with nephropathy E20.1 Pseudohypoparathyroidism B25.1 Cytomegaloviral hepatitis E28.2 Polycystic Ovarian Syndrome B25.2 Cytomegaloviral pancreatitis E34.0 Carcinoid syndrome B52.0 Plasmodium malariae malaria with nephropathy E41 Nutritional marasmus C00.0 – C96.9 All types of Cancer code (range) E42 Marasmic kwashiorkor C96.A Histiocytic sarcoma E43 Unspecified severe protein-calorie malnutrition Other specified malignant neoplasms of C96.Z lymphoid, hematopoietic and related tissue E44.0 – E46 Moderate protein-calorie malnutrition (range) D00.00 – D09.9 Carcinoma code (range) E50 – E50.9 Vitamin A deficiency (range) D63.0 Anemia in neoplastic disease E51 – E51.9 Thiamine deficiency (range) D64.81 Anemia due to antineoplastic chemotherapy E52 Niacin deficiency [pellagra] Agranulocytosis secondary to cancer D70.1 E53.0 – E53.9 Deficiency of other B group vitamins (range) chemotherapy E54 Ascorbic acid deficiency D70.2 Other drug-induced agranulocytosis E55.0 – E55.9 Vitamin D deficiency Iron deficiency anemia secondary to blood loss D50.0 – D50.1 (range) E56.0 – E56.9 Other vitamin deficiencies D50.8 – D50.9 Other iron Deficiency Anemia (range) E58 Dietary calcium deficiency D51.0
    [Show full text]
  • Urology/ Nephrology a Comprehensive Illustrated Guide to Coding and Reimbursement
    CODING COMPANION Urology/ Nephrology A comprehensive illustrated guide to coding and reimbursement Sample 2021 optum360coding.com Contents Getting Started with Coding Companion..................................i Penis................................................................................................... 327 CPT Codes ...............................................................................................i Testis ................................................................................................. .363 ICD-10-CM...............................................................................................i Epididymis........................................................................................ 378 Detailed Code Information.................................................................i Tunica Vaginalis .............................................................................. 385 Appendix Codes and Descriptions....................................................i Scrotum............................................................................................. 388 CCI Edit Updates....................................................................................i Vas Deferens .................................................................................... 393 Index.........................................................................................................i Spermatic Cord................................................................................ 397 General Guidelines
    [Show full text]
  • Online Supplement
    1 Online supplement Table 1. Hospital types Hospital type Number Small hospitals with acute function 21 Large hospitals with acute function 22 Regional hospitals 4 Table 2. Laparotomy cases after operation type (primary episode) Operation type Frequency, n (%) Gastrointestinal tract 30 404 (38.9) More than one type of surgerya 14 051 (18.0) Female genital organs 10 720 (13.7) Other urinary and male genital organs 6 536 (8.4) Peripheral vascular surgery 4 628 (5.9) Biliary tract 2 739 (3.5) Other digestive system 2 226 (2.9) Kidney 2 152 (2.8) Exploratory laparotomy 2 061 (2.6) Liver 1 122 (1.4) Pancreas 775 (1.0) Hernia (diaphragmal) 274 (0.4) Spleen 248 (0.3) Thoracoabdominal aorta 150 (0.2) aNot counting exploratory laparotomy Table 3. Effect of hospital region, after risk adjustment. Odds ratio standardized to have geometric mean one. Hospital region Adjusted odds ratio (95% confidence interval) South-Eastern Norway Region 0.85 (0.78 - 0.92) Central Norway Region 0.99 (0.89 - 1.10) Western Norway Region 1.06 (0.96 - 1.17) Northern Norway Region 1.13 (1.001 - 1.27) Postoperative wound dehiscence after laparotomy: a useful health care quality indicator? A cohort study based on Norwegian hospital administrative data 2 Diagnoses Table 4. ICD-10 diagnosis codes contained in MDC 14 (Pregnancy, childbirth, and puerperium) Code Title A34 Obstetrical tetanus F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified F53.1 Severe mental and behavioural disorders associated with the puerperium, not elsewhere
    [Show full text]
  • Icd-10Causeofdeath.Pdf
    A00 Cholera A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae A00.1 Cholera due to Vibrio cholerae 01, biovar el tor A00.9 Cholera, unspecified A01 Typhoid and paratyphoid fevers A01.0 Typhoid fever A01.1 Paratyphoid fever A A01.2 Paratyphoid fever B A01.3 Paratyphoid fever C A01.4 Paratyphoid fever, unspecified A02 Other salmonella infections A02.0 Salmonella gastroenteritis A02.1 Salmonella septicemia A02.2 Localized salmonella infections A02.8 Other specified salmonella infections A02.9 Salmonella infection, unspecified A03 Shigellosis A03.0 Shigellosis due to Shigella dysenteriae A03.1 Shigellosis due to Shigella flexneri A03.2 Shigellosis due to Shigella boydii A03.3 Shigellosis due to Shigella sonnei A03.8 Other shigellosis A03.9 Shigellosis, unspecified A04 Other bacterial intestinal infections A04.0 Enteropathogenic Escherichia coli infection A04.1 Enterotoxigenic Escherichia coli infection A04.2 Enteroinvasive Escherichia coli infection A04.3 Enterohemorrhagic Escherichia coli infection A04.4 Other intestinal Escherichia coli infections A04.5 Campylobacter enteritis A04.6 Enteritis due to Yersinia enterocolitica A04.7 Enterocolitis due to Clostridium difficile A04.8 Other specified bacterial intestinal infections A04.9 Bacterial intestinal infection, unspecified A05 Other bacterial food-borne intoxications A05.0 Food-borne staphylococcal intoxication A05.1 Botulism A05.2 Food-borne Clostridium perfringens [Clostridium welchii] intoxication A05.3 Food-borne Vibrio parahemolyticus intoxication A05.4 Food-borne Bacillus cereus
    [Show full text]
  • WO 2017/152149 Al 8 September 2017 (08.09.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/152149 Al 8 September 2017 (08.09.2017) P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K 48/00 (2006.01) C12N 15/64 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, C12N 15/09 (2006.01) C12N 15/66 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, (21) International Application Number: KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, PCT/US20 17/020828 MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, (22) International Filing Date: NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, 3 March 2017 (03.03.2017) RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, (25) Filing Language: English ZA, ZM, ZW. (26) Publication Language: English 4 Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 62/303,047 3 March 2016 (03.03.2016) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 62/394,720 14 September 2016 (14.09.2016) u s TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, 62/406,9 13 11 October 2016 ( 11.
    [Show full text]